Skip to content

Breaking down the silos: integrating hepatitis C 'test and treat' services into ART clinics is possible

Chukwuemeka Agwuocha presenting at IAS 2023.

Mumbai shows triaging those with advanced HIV disease in government centres is feasible

Luvin Yash/Shutterstock.com

Immediate ART associated with fewer deaths in Thailand, but starting a week or two later may lead to less virological failure

Sirinya Teeraananchai at IAS 2023.

Immune-modulating medication may help clear HIV reservoir

Monica Reece presenting at IAS 2023. Photo by Emily Edwards.

Injectable HIV treatment unlikely to be arriving soon in the global south

Dr Carolyn Bolton Moore at IAS 2023.

Adherence counselling reverses viral rebound on dolutegravir in 95% of cases

Dr Andrew Hill at IAS 2023. Photo by Roger Pebody.

What’s happened to services for key populations in Uganda following the Anti-Homosexuality Act?

US Ambassador to Uganda Natalie Brown at IAS 2023. Photo by Roger Pebody.

Two modelling studies ask: will injectable PrEP ever be cost-effective at achievable prices?

Dr Anne Neilan presenting the South African study at IAS 2023.

People with HIV are not at greater risk for severe mpox unless they are immunosuppressed

Ana Hoxha at IAS 2023.